North America Mutation Detection Kits In Genome Editing Market Size & Outlook

The mutation detection kits in genome editing market in North America is expected to reach a projected revenue of US$ 173,550.2 million by 2028. A compound annual growth rate of 17.2% is expected of North America mutation detection kits in genome editing market from 2021 to 2028.
Revenue, 2020 (US$M)
$48,796.9
Forecast, 2028 (US$M)
$173,550.2
CAGR, 2021 - 2028
17.2%
Report Coverage
North America

North America mutation detection kits in genome editing market, 2017-2028 (US$M)

North

North America mutation detection kits in genome editing market highlights

  • The North America mutation detection kits in genome editing market generated a revenue of USD 48,796.9 million in 2020.
  • The market is expected to grow at a CAGR of 17.2% from 2021 to 2028.
  • In terms of segment, (crispr)/cas9 was the largest revenue generating technology in 2020.
  • Meganuclease is the most lucrative technology segment registering the fastest growth during the forecast period.
  • Country-wise, Canada is expected to register the highest CAGR from 2021 to 2028.


North America data book summary

Market revenue in 2020USD 48,796.9 million
Market revenue in 2028USD 173,550.2 million
Growth rate17.2% (CAGR from 2020 to 2028)
Largest segment(crispr)/cas9
Fastest growing segmentMeganuclease
Historical data covered2017 - 2019
Base year for estimation2020
Forecast period covered2021 - 2028
Quantitative unitsRevenue in USD million
Market segmentation(CRISPR)/Cas9, TALENs/MegaTALs, ZFN, Meganuclease
Key market players worldwideThermo Fisher Scientific Inc, Takara Bio Inc, Danaher Corp, Promega, GenScript ProBio, New England Biolabs, Applied Materials Inc, Bio-Rad Laboratories Inc, Lucigen, Synthego, Addgene, Abcam PLC


Other key industry trends

  • In terms of revenue, North America region accounted for 38.4% of the global mutation detection kits in genome editing market in 2020.
  • Globally, North America is projected to lead the regional market in terms of revenue in 2028.
  • Asia Pacific is the fastest growing regional market and is projected to reach USD 162,918.0 million by 2028.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Mutation Detection Kits In Genome Editing Market Scope

Mutation detection kits in genome editing market segmentation & scope
Genetically Modified Organisms (GMO) analysis
Disease genotyping
Typing of transgenic plants
Therapy development
Epigenetic editing
Other Applications
Genetically Modified Organisms (GMO) analysis
Disease genotyping
Typing of transgenic plants
Therapy development
Epigenetic editing
Other Applications
ZFN
Genetically Modified Organisms (GMO) analysis
Disease genotyping
Typing of transgenic plants
Therapy development
Epigenetic editing
Other Applications
Genetically Modified Organisms (GMO) analysis
Disease genotyping
Typing of transgenic plants
Therapy development
Epigenetic editing
Other Applications
Others
Biotechnology and pharmaceutical companies
Academic and government research institutes
Contract research organizations

Mutation Detection Kits In Genome Editing Market Companies

Name Profile # Employees HQ Website

North America mutation detection kits in genome editing market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to mutation detection kits in genome editing market will help companies and investors design strategic landscapes.


(crispr)/cas9 was the largest segment with a revenue share of 42.99% in 2020. Horizon Databook has segmented the North America mutation detection kits in genome editing market based on (crispr)/cas9, talens/megatals, zfn, meganuclease covering the revenue growth of each sub-segment from 2017 to 2028.


High investments in R&D, continuous technological developments by key players, availability of technologically advanced healthcare infrastructure, and a strong regional economy have resulted in North America’s current dominance in the global market. In addition, local presence of key operating players in the region can further strengthen regional revenue generation.

GeneScript, Thermo Fisher Scientific, Takara Bio USA are some prominent players operating in North America. Furthermore, government initiatives in the U.S. and Canada are supporting research in therapeutic development in oncology space.

For instance, the Personalized Onco-Genomics program of the BC Cancer utilizes whole-genome and transcriptome analysis for the determination of cancer genes and identification of corresponding drugs that may inhibit relevant pathways in cancer-affected patients.

Reasons to subscribe to North America mutation detection kits in genome editing market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of North America mutation detection kits in genome editing market databook

  • Our clientele includes a mix of mutation detection kits in genome editing market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of continent-level data and insights on the North America mutation detection kits in genome editing market , including forecasts for subscribers. This continent databook contains high-level insights into North America mutation detection kits in genome editing market from 2017 to 2028, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

North America mutation detection kits in genome editing market size, by country, 2017-2028 (US$M)

North America Mutation Detection Kits In Genome Editing Market Outlook Share, 2020 & 2028 (US$M)

North America mutation detection kits in genome editing market size, by country, 2017-2028 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more